JP2024529044A5 - - Google Patents
Info
- Publication number
- JP2024529044A5 JP2024529044A5 JP2024507020A JP2024507020A JP2024529044A5 JP 2024529044 A5 JP2024529044 A5 JP 2024529044A5 JP 2024507020 A JP2024507020 A JP 2024507020A JP 2024507020 A JP2024507020 A JP 2024507020A JP 2024529044 A5 JP2024529044 A5 JP 2024529044A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- lic
- lmanv2
- nos
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230244P | 2021-08-06 | 2021-08-06 | |
| US63/230,244 | 2021-08-06 | ||
| PCT/US2022/074601 WO2023015290A1 (en) | 2021-08-06 | 2022-08-05 | Leptospiral virulence modulating proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529044A JP2024529044A (ja) | 2024-08-01 |
| JP2024529044A5 true JP2024529044A5 (enExample) | 2025-08-14 |
Family
ID=85156339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507020A Pending JP2024529044A (ja) | 2021-08-06 | 2022-08-05 | レプトスピラ病毒性調節タンパク質とその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240277823A1 (enExample) |
| EP (1) | EP4380608A4 (enExample) |
| JP (1) | JP2024529044A (enExample) |
| CN (1) | CN117979992A (enExample) |
| AU (1) | AU2022323324A1 (enExample) |
| WO (1) | WO2023015290A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025208019A1 (en) * | 2024-03-29 | 2025-10-02 | Yale University | Leptospiral virulence modulating protein epitopes and uses thereof |
| WO2026006400A2 (en) * | 2024-06-25 | 2026-01-02 | Luna Bioscience, Inc. | A virulence modifying protein-based recombinant vaccine and rapid diagnostic assay for leptospira |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200700263A1 (ru) * | 2004-07-01 | 2007-06-29 | Кебенхавнс Университет | Способ лечения и профилактики рассеянного склероза путём лечения лептоспирозной инфекции |
| AU2016219787B2 (en) * | 2015-02-20 | 2019-05-30 | Calixar | Leptospira immunoprotective proteins and methods of identification and use thereof |
| EP4100050A4 (en) * | 2020-02-07 | 2024-07-10 | Yale University | Leptospiral proteins and uses thereof |
-
2022
- 2022-08-05 WO PCT/US2022/074601 patent/WO2023015290A1/en not_active Ceased
- 2022-08-05 CN CN202280062844.1A patent/CN117979992A/zh active Pending
- 2022-08-05 US US18/681,192 patent/US20240277823A1/en active Pending
- 2022-08-05 AU AU2022323324A patent/AU2022323324A1/en active Pending
- 2022-08-05 JP JP2024507020A patent/JP2024529044A/ja active Pending
- 2022-08-05 EP EP22854119.9A patent/EP4380608A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2528815B2 (ja) | 多効果免疫性蛋白質 | |
| JP2000516200A (ja) | ウシの呼吸病に対するポリヌクレオチドワクチン処方 | |
| JP2022553826A5 (enExample) | ||
| CA2939862A1 (en) | Uspa2 protein constructs and uses thereof | |
| CA2399790A1 (en) | Cd40 ligand adjuvant for respiratory syncytial virus | |
| Zhang et al. | Characterization of OmpK, GAPDH and their fusion OmpK–GAPDH derived from Vibrio harveyi outer membrane proteins: their immunoprotective ability against vibriosis in large yellow croaker (Pseudosciaena crocea) | |
| JP6172582B2 (ja) | 豚の浮腫病を予防するワクチン | |
| CN115944722A (zh) | 一种抗肿瘤mRNA疫苗及其制备方法和应用 | |
| WO2023138334A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| WO2024222926A1 (zh) | 可自组装为纳米颗粒的融合蛋白及其在免疫中的应用 | |
| JP2023086734A5 (enExample) | ||
| Chuekwon et al. | N-terminus of flagellin enhances vaccine efficacy against Actinobacillus pleuropneumoniae | |
| ES2282992T3 (es) | Vacuna para cepa de haemophilus influenzae no tipificable. | |
| US20250042962A1 (en) | Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use | |
| WO2023138333A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| JP4005633B2 (ja) | Ｆ型ボツリヌス毒素およびその用途 | |
| JP7045024B2 (ja) | マラリアワクチン | |
| JP2015500226A (ja) | ポリペプチドアジュバント | |
| LU504032B1 (en) | Recombinant protein and foot-and-mouth disease virus-like particle vaccine, and preparation method and application thereof | |
| CN117177766A (zh) | 疫苗平台 | |
| US12121574B2 (en) | Malaria immunogen and methods for using same | |
| CN105622762A (zh) | 一种牛趋化因子介导的o型口蹄疫靶向性复合表位蛋白及疫苗 | |
| Poulain‐Godefroy et al. | Adjuvant activity of free Bordetella pertussis filamentous haemagglutinin delivered by mucosal routes | |
| US20260130979A1 (en) | Malaria immunogen and methods of using same | |
| Meng et al. | Primary evaluation of immune responses in mice after a single mRNA immunization with Echinococcus granulosus Eg95 and Coenurus cerebralis TM16 |